Cargando…

Seroprevalence of Chikungunya Virus after Its Emergence in Brazil

Chikungunya has had a substantial impact on public health because of the magnitude of its epidemics and its highly debilitating symptoms. We estimated the seroprevalence, proportion of symptomatic cases, and proportion of chronic form of disease after introduction of chikungunya virus (CHIKV) in 2 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dias, Juarez P., Costa, Maria da Conceição N., Campos, Gubio Soares, Paixão, Enny S., Natividade, Marcio S., Barreto, Florisneide R., Itaparica, Martha Suely C., Goes, Cristina, Oliveira, Francisca L.S., Santana, Eloisa B., Silva, Neusa S.J., Brito, Carlos A.A., Rodrigues, Laura C., Sardi, Silvia Inez, Saavedra, Ramon C., Teixeira, Maria Glória
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875253/
https://www.ncbi.nlm.nih.gov/pubmed/29553317
http://dx.doi.org/10.3201/eid2404.171370
Descripción
Sumario:Chikungunya has had a substantial impact on public health because of the magnitude of its epidemics and its highly debilitating symptoms. We estimated the seroprevalence, proportion of symptomatic cases, and proportion of chronic form of disease after introduction of chikungunya virus (CHIKV) in 2 cities in Brazil. We conducted the population-based study through household interviews and serologic surveys during October–December 2015. In Feira de Santana, we conducted a serologic survey of 385 persons; 57.1% were CHIKV-positive. Among them, 32.7% reported symptoms, and 68.1% contracted chronic chikungunya disease. A similar survey in Riachão do Jacuípe included 446 persons; 45.7% were CHIKV-positive, 41.2% reported symptoms, and 75.0% contracted the chronic form. Our data confirm intense CHIKV transmission during the continuing epidemic. Chronic pain developed in a high proportion of patients. We recommend training health professionals in management of chronic pain, which will improve the quality of life of chikungunya-affected persons.